Experiences with
Veklury

4 public posts

FDA Could Soon Limit Use of Only Drug for COVID Prevention - i.e.,Pemivibart may have reduced activity against growing variant KP.3.1.1

[/i] [i]Several COVID-19 treatments -- nirmatrelvir/ritonavir (Paxlovid), remdesivir (Veklury), and molnupiravir (Lagevrio) -- are expected to work against currently circulating variants, and are approved or authorized to treat patients with mild-to-moderate COVID-19 who are at high risk for progression

[/i] [i]Several COVID-19 treatments -- nirmatrelvir/ritonavir (Paxlovid), remdesivir (Veklury), and molnupiravir (Lagevrio) -- are expected to work against currently circulating variants, and are approved or authorized to treat patients with mild-to-moderate COVID-19 who are at high risk for progression

3 months ago

COVID update: Who remains at higher risk? by LLS.org

Paxlovid and Legevrio are taken orally (capsules or tablets) for 5 days, while Veklury must be given in a medical facility as an injection or infusion. Veklury can also be used for hospitalized patients.

Paxlovid and Legevrio are taken orally (capsules or tablets) for 5 days, while Veklury must be given in a medical facility as an injection or infusion. Veklury can also be used for hospitalized patients.

Volunteerin CLL Support

2 years ago

COVID: Staying Safe As The Virus Evolves - LLS Podcast / CLL Society’s COVID-19 Update December 5th, 2022 / Dec 15 2022 end Antibody Study

Paxlovid and Legevrio are taken orally (capsules or tablets) for 5 days, while Veklury must be given in a medical facility as an injection or infusion. Veklury can also be used for hospitalized patients.

Paxlovid and Legevrio are taken orally (capsules or tablets) for 5 days, while Veklury must be given in a medical facility as an injection or infusion. Veklury can also be used for hospitalized patients.

Volunteerin CLL Support

2 years ago

Want to take advantage of all our features? Just log in!

or

EvuSheld in the Uk

This could be either sotrovimab or nirmatrelvir with ritonavir (Paxlovid), and those who are unable to receive these treatments will be offered remdesivir (Veklury) and then molnupiravir.

This could be either sotrovimab or nirmatrelvir with ritonavir (Paxlovid), and those who are unable to receive these treatments will be offered remdesivir (Veklury) and then molnupiravir.

3 years ago